My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adverum Biotechnologies, Inc. - Common Stock (NQ:ADVM)

5.390 +0.120 (+2.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 323,233
Open 5.400
Bid (Size) 5.210 (2)
Ask (Size) 5.490 (7)
Prev. Close 5.270
Today's Range 5.150 - 5.548
52wk Range 1.780 - 8.560
Shares Outstanding 98,125,866
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
In today's session, these stocks are experiencing unusual volume.
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga

Performance

YTD
+12.3%
+12.3%
1 Month
+65.8%
+65.8%
3 Month
+141.7%
+141.7%
6 Month
+39.6%
+39.6%
1 Year
-26.0%
-26.0%

More News

Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
Top movers in Wednesday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q2 2024
Via InvestorPlace
Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study
Via Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Misses EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023
Via InvestorPlace

Frequently Asked Questions

Is Adverum Biotechnologies, Inc. - Common Stock publicly traded?
Yes, Adverum Biotechnologies, Inc. - Common Stock is publicly traded.
What exchange does Adverum Biotechnologies, Inc. - Common Stock trade on?
Adverum Biotechnologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adverum Biotechnologies, Inc. - Common Stock?
The ticker symbol for Adverum Biotechnologies, Inc. - Common Stock is ADVM on the Nasdaq Stock Market
What is the current price of Adverum Biotechnologies, Inc. - Common Stock?
The current price of Adverum Biotechnologies, Inc. - Common Stock is 5.390
When was Adverum Biotechnologies, Inc. - Common Stock last traded?
The last trade of Adverum Biotechnologies, Inc. - Common Stock was at 10/03/25 04:00 PM ET
What is the market capitalization of Adverum Biotechnologies, Inc. - Common Stock?
The market capitalization of Adverum Biotechnologies, Inc. - Common Stock is 528.90M
How many shares of Adverum Biotechnologies, Inc. - Common Stock are outstanding?
Adverum Biotechnologies, Inc. - Common Stock has 529M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.